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ABSTRACT 
Background Emergence of chloroquine (CQ) resistance among different strains of 
Plasmodium falciparum is the worst incident that has ever faced the dedicated efforts to 
eradicate malaria. The main cause of CQ resistance is over-activity of the pumping 
mechanism that ousts CQ outside the DV. This urged the scientists to look for other 
alternatives or adjuvants that augment its action. CQ The study aimed to test the potential of 
five coumarin derivatives, namely; umbeliferon, esculetin, scopoletine, herniarin and 3-
aminocoumarine to inhibit plasmodium growth and reverse CQ resistance in Plasmodium 
falciparum K1 and 3D7. They are highly ubiquitous in nature and are famous by their diverse 
pharmacological effects. SYBRE green-1 based drug sensitivity assay was used to screen the 
effect of CQ and each coumarin on the parasite growth and isobologram technique was to 
assess the interaction of the coumarins with CQ. Effect of each coumarin on both RBCs and 
Vero cells stability as well as on RBCs fragility were screened to exclude any toxic impact on 
normal cells. On the other hand, their effect on hemozoin formation was screened to 
investigate about their molecular mechanism. For molecular characterization, Their 
antioxidant properties were determined using the conventional in vitro tests and their 
characters were obtained from Molinspiration Simulation Software. Results showed that all 
of them were safe to human cells, have weak to moderate plasmodial growth inhibitory effect 
and only umbeliferon, 3- aminocoumarin and esculetin has interacted effectively with CQ. 
These actions are neither correlated with hemozoin formation inhibition nor to the antioxidant 
mechanisms. Further studies recommended to investigate the mechanism of their action. 
Overall, all the tested coumarins are not ideal to be used in the conventional malaria therapy 
and only umbeliferon, 3-aminocoumarin and esculetin can be suggested to potentiate CQ 
action. 
